Genesis IBRC Stock Screener | Share Price & Fundamental Analysis

GENESIS Biotechnology
Screen Genesis IBRC share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹87.27
▲ 4.15 (4.99%)
2026-01-07 00:00:00
Market Cap ₹119.07 Cr.
P/B Ratio 13.59
EPS (TTM) ₹-0.03
Dividend Yield -
Debt to Equity 0.15
52W High ₹184.90
52W Low ₹17.47
Operating Margin -
Profit Margin -
EBITDA -
Net Income -
Total Assets ₹12.00
Total Equity ₹10.00

Genesis IBRC Share Price History - Stock Screener Chart

Screen GENESIS historical share price movements with interactive charts. Analyze price trends and patterns.

Genesis IBRC Company Profile - Fundamental Screener

Screen Genesis IBRC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GENESIS shares.
Sector Healthcare
Industry Biotechnology
Sub-Sector Biotechnology
Segment E
ISIN INE194N01016

Genesis IBRC Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen GENESIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2018
Assets
Total Assets 12
Current Assets 7
Fixed Assets 2
Liabilities
Total Liabilities 12
Current Liabilities 0
Non-Current Liabilities 0
Shareholders' Equity
Total Equity 10
Share Capital 13
Reserves & Surplus -3
Screen GENESIS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item None-None 2018-March
Revenue 0 4
Expenses 0 4
EBITDA 0 0
Operating Profit % 0.00% 4.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax 0 0
Tax 0 0
Net Profit 0 0
EPS 0.00 -0.03

Genesis IBRC Cash Flow Screener - Liquidity Fundamentals

Screen GENESIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2018-March
Operating Activities 2
Investing Activities -5
Financing Activities 3
Net Cash Flow 0
Screen GENESIS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 11.33% 11.33% 11.33% 11.33% 11.33% 11.33% 11.33% 11.33%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 32.00% 32.00% 32.00% 49.31% 49.31% 49.31% 49.31% 49.31%
Other Holding 56.66% 56.66% 56.66% 39.36% 39.36% 39.36% 39.36% 39.36%
Shareholder Count 1,747 1,731 1,736 1,749 1,750 1,751 1,751 1,749

Genesis IBRC Dividend Screener - Share Yield Analysis

Screen GENESIS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Genesis IBRC.

Genesis IBRC Index Membership - Market Screener Classification

Screen GENESIS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Genesis IBRC is not part of any tracked indices.
Only major market indices are tracked in our system.

Genesis IBRC Market Events Screener - Corporate Actions

Screen GENESIS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 4.97%
Annual General Meeting NA 79.36%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 3.95%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 15.73%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 0.00%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 0.00%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 4.98%
2018-01-12 2018-01-12 Change Of Name NA -

Genesis IBRC Competitors Screener - Peer Comparison

Screen GENESIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Anthem Biosciences 36,224 71.34 1,930 30.15% 451 44.48
Advanced Enzyme Tech 3,372 23.19 670 1.44% 134 45.49
Genesis IBRC 119 -484.83 4 % 0 42.21
Vivo Bio Tech 69 17.45 52 13.19% 7 50.67
Shree Ganesh Bio-Tech 28 24 14.55% 0 64.94
Genomic Valley Biotech 8 76.24 1 300.00% 0 52.18

Genesis IBRC Company Announcements - News Screener

Screen GENESIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-07 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 View
2026-01-02 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer View
2025-12-26 Closure of Trading Window View
2025-12-23 Post-Offer Public Announcement View
2025-11-25 Pre-offer Advertisement and Corrigendum to the Detailed Public Statement View
2025-11-24 Updates on Open Offer View
2025-11-22 Updates on Open Offer View
2025-11-22 Updates on Open Offer View
2025-11-19 Letter of Offer View
2025-11-14 Statement Of Deviation And Variation View
2025-11-14 Results For The Quarter Ended On 30.09.2025 View
2025-11-14 Board Meeting Outcome for Outcome Of The Meeting View
2025-11-05 Board Meeting Intimation for Notice Of Board Meeting To Be Held On Friday The 14Th Day Of November 2025 View
2025-10-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-26 Closure of Trading Window View
2025-09-03 Reg. 34 (1) Annual Report. View
2025-09-03 Notice Of 33Rd Annual General Meeting (AGM) And Annual Report Of The Company For The F Y 2024-25 View
2025-08-29 Board Meeting Outcome for Outcome Of The Board Meeting Held On 29.08.2025 View